These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 2573905)
1. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Li AA; Marek GJ; Vosmer G; Seiden LS Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905 [TBL] [Abstract][Full Text] [Related]
2. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
3. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Matthews RT; Champney TH; Frye GD Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758 [TBL] [Abstract][Full Text] [Related]
4. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
5. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304 [TBL] [Abstract][Full Text] [Related]
7. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Stone DM; Stahl DC; Hanson GR; Gibb JW Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893 [TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems. Nader MA; Hoffmann SM; Barrett JE Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215 [TBL] [Abstract][Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
10. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482 [TBL] [Abstract][Full Text] [Related]
11. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999 [TBL] [Abstract][Full Text] [Related]
12. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats. Miller RT; Lau SS; Monks TJ Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050 [TBL] [Abstract][Full Text] [Related]
13. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Baumann MH; Wang X; Rothman RB Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine. Nencini P; Woolverton WL; Seiden LS Brain Res; 1988 Aug; 457(1):136-42. PubMed ID: 2901895 [TBL] [Abstract][Full Text] [Related]
15. Orally administered MDMA causes a long-term depletion of serotonin in rat brain. Finnegan KT; Ricaurte GA; Ritchie LD; Irwin I; Peroutka SJ; Langston JW Brain Res; 1988 Apr; 447(1):141-4. PubMed ID: 2898273 [TBL] [Abstract][Full Text] [Related]
16. 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Ricaurte GA; Finnegan KF; Nichols DE; DeLanney LE; Irwin I; Langston JW Eur J Pharmacol; 1987 Jun; 137(2-3):265-8. PubMed ID: 2886355 [TBL] [Abstract][Full Text] [Related]
17. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related]
18. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
19. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Stone DM; Merchant KM; Hanson GR; Gibb JW Neuropharmacology; 1987 Dec; 26(12):1677-83. PubMed ID: 2893986 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]